CN110079511A - A kind of RNA polymerase preparation method and application that RNA is relied on - Google Patents

A kind of RNA polymerase preparation method and application that RNA is relied on Download PDF

Info

Publication number
CN110079511A
CN110079511A CN201910457310.9A CN201910457310A CN110079511A CN 110079511 A CN110079511 A CN 110079511A CN 201910457310 A CN201910457310 A CN 201910457310A CN 110079511 A CN110079511 A CN 110079511A
Authority
CN
China
Prior art keywords
rna
cell
culture
rna polymerase
polymerase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201910457310.9A
Other languages
Chinese (zh)
Inventor
李正和
许凯
裘炀琳
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201910457310.9A priority Critical patent/CN110079511A/en
Publication of CN110079511A publication Critical patent/CN110079511A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/12Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241Nucleotidyltransferases (2.7.7)
    • C12N9/127RNA-directed RNA polymerase (2.7.7.48), i.e. RNA replicase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y207/00Transferases transferring phosphorus-containing groups (2.7)
    • C12Y207/07Nucleotidyltransferases (2.7.7)
    • C12Y207/07048RNA-directed RNA polymerase (2.7.7.48), i.e. RNA replicase

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

The present invention discloses a kind of RNA polymerase preparation method and application that RNA is relied on, the preparation method is using Carmovirus virus as raw material, viral replication protein using transmembrane region or cross-film region mutation containing polymerase domain and without the end N- is basic preparation and reorganization albumen, the RNA polymerase that there is RNA to rely on is obtained, specially chooses the Carmovirus virus of Tombusviridae first as raw material;Then using the transmembrane region for the end N- for truncating or being mutated removing viral RNA, template ribonucleic acid is obtained;Carry out the synthesis of RNA polymerase in the cell or extracellularly finally by prokaryotic expression or eukaryotic expression;Recombinant protein is obtained using method of the invention, RNA yield is greater than 1 mg/ml, is suitble to the synthesis and production of industrialization RNA.

Description

A kind of RNA polymerase preparation method and application that RNA is relied on
Technical field
The invention belongs to enzyme production technical fields, specifically, be related to a kind of RNA polymerase preparation method that RNA is relied on Using.
Background technique
RNA is one of eukaryocyte and prokaryotic cell important component, and it is a variety of important that it participates in transcription, translation etc. Function, transcription are genomic information transfer, and genomic information refers to DNA information, this information is transferred to cell by nucleus Matter, translation, which refers to, is translated as amino acid or protein for transcriptional information, and RNA polymerase is using a DNA chain or RNA as mould Plate, triphosphoric acid ribonucleotide be substrate, by phosphodiester bond polymerize synthesis RNA enzyme because in the cell with gene It is related that the hereditary information of DNA is transcribed into RNA, so also referred to as transcriptase;
In the prior art, RNA can not be efficiently synthesized by RNA template, therefore causes the technology that can not be applied to industry Metaplasia produces, and in order to solve this problem, the present invention provides following technical schemes.
Summary of the invention
The purpose of the present invention is to provide a kind of RNA RNA polymerase preparation method relied on and applications.
The technical problem to be solved in the invention are as follows:
In the prior art, it can not be efficiently synthesized RNA by template of RNA, led to not poly- suitable for industrialized RNA Synthase synthesis and production.
The purpose of the present invention can be achieved through the following technical solutions:
A kind of RNA polymerase preparation method that RNA is relied on, includes the following steps:
A, Tombusviridae (Tombusviridae) Carmovirus (Carmovirus) virus is chosen to make For raw material;
B, using the transmembrane region for the end N- for truncating or being mutated removing viral RNA, to remove the cytotoxicity of virus protein And enhance the solubility of recombinant protein;
C, the synthesis of RNA polymerase is carried out in the cell or extracellularly by prokaryotic expression or eukaryotic expression.
As further scheme of the invention, the specific side of the transmembrane region of the end N- is removed in the step b by mutation Method is deletion mutation or point mutation;
As further scheme of the invention, in extracellularly preparation target RNA, RNA polymerase passes through protokaryon table first Reach or eukaryotic expression after purify, become enzyme preparation, in extracellular buffered environment, utilize target template RNA synthesis complementary Chain RNA, in one embodiment of the invention, buffer is by 100mM KCl, 5mM MgCl2With the 50mM Tris- of pH 7.5 HCl composition;
As further scheme of the invention, when preparing target RNA in the cell, polymerase template ribonucleic acid is constructed true In nuclear expression carrier, after expressing in eukaryocyte, complementary strand RNA is synthesized using intracellular target template RNA;The eukaryon Expression vector includes but is not limited to mammalian expression vector, insect expression vector, Yeast expression carrier;
Wherein, polymerase template ribonucleic acid is constructed into the method in carrier for expression of eukaryon are as follows:
The adhere-wall culture of S1, cell
Cell to be transfected is added in culture bottle, cell to be transfected, after cleaning, Xiang Qi are cleaned by PBS buffer solution Middle addition pancreatin is digested by pancreatin and decomposes extracellular protein, so that the cell being bonded together be made to separate, passes through micro- sem observation Cell separates situation, when cell is without large stretch of connection, serum is added into culture bottle, wherein serum is able to suppress and destroys pancreas Enzymatic activity makes its failure, prevents pancreatin excessive decomposition extracellular protein, damages to cell itself;
Centrifugation obtains agglomerate cell, is centrifuged again after being cleaned by PBS buffer solution, PBS buffer solution is removed, into cell MEM culture medium is added and dispels cell, cell culture medium is added in culture bottle, in the environment of 37 DEG C, 5% carbon dioxide Stationary culture, keeps cell adherent and flanking cell does not bond mutually, and wherein the adherent area of cell accounts for culture bottle bottom of bottle area 60%-80%;
The case where cell of culture is separated first in the step, avoids the occurrence of multiple cell agglomerates, to cell phase Mutually after dispersion, then the cell being dispersed is cultivated, makes cell adherent growth, be able to ascend in this way cell expose it is thin The area of after birth, to promote the efficiency of subsequent processing;
The preparation of S2, transfection liquid
Polylea non-liposomal transfection reagent is added into physiological saline, ethyl alcohol is added thereto after concussion is uniformly dispersed With A23187 carrier, it is stand-by that precursor is obtained after concussion dispersion;
The polymerase template ribonucleic acid for being 0.1-1g/L by MEM culture medium compound concentration, is then added dropwise in precursor, Container is constantly shaken during being added dropwise, and is uniformly mixed the two;
S3, transfection
After the culture bottle that inner wall adherent growth obtained in step S1 has cell is taken out, culture solution is poured out, to culture Transfection liquid is added dropwise in bottle, and transfection liquid slides into along bottle wall when dropwise addition, prevents cell and culture bottle of the droplet impact power by adherent growth Separation;
By culture bottle in the environment of 37 DEG C, 5% carbon dioxide after stationary culture 10-15min, it is ultrasonically treated 20- 26min completes transfection after then cultivating 4-8h in the environment of 37 DEG C, 5% carbon dioxide.
During being ultrasonically treated, in order to guarantee that the uniformity of ultrasound, ultrasound occur point and culture bottle are arranged in Underface, and the distance between point and culture bottle >=15cm occur for ultrasound;
In this step, first by cell in culture bottle in the environment of 37 DEG C, 5% carbon dioxide stationary culture 10- 15min, during this, calcium ion concentration is increased rapidly in A23187 carrier inducing cell, to promote the intake energy of cell Power promotes the sponginess of cell membrane surface using ultrasound then by ultrasonic treatment, and polymerase template ribonucleic acid is accelerated to enter cell It is interior, finally so that polymerase template ribonucleic acid is completed transfection, when whole process shortens transfection culture by ultrasound by stationary culture again Between, while sonication treatment time is shortened by A23187 carrier function, that is, achieve the effect that shorten transfection time, and will not be big It is big to extend ultrasonic time, guarantee cyto-architectural integrality.
As further scheme of the invention, to the albumen of viral source can by but be not limited to addition sequence label Mode, in order to the purifying after protokaryon or eukaryotic expression;
As further scheme of the invention, the method for improving polymerase enzyme activity includes but is not limited to: improving intracellular The copy number of gene, the expression for improving enzyme change the sequence of enzyme to improve stability, remove the amino acid for causing to inhibit Residue and the transhipment and aggregation intracellular for changing protein;
It is double by will be formed with the short rna of target template RNA complementary pairing and template as further scheme of the invention Chain structure can promote the synthesis of complementary strand RNA using the duplex structure as primer, improve RNA combined coefficient;
As further scheme of the invention, by being to be matched with self-complementary by the 3 ' tip designs of target template RNA, And using the end RNA after pairing as primer, the synthesis of complementary strand RNA can be promoted.
In one embodiment of the invention, Tombusviridae (Tombusviridae) described in the step a is fragrant It is specially turnip crinkle virus (Turnip crinkle virus) that China pink mottle virus, which belongs to virus, wherein turnip crinkle virus In replication protein coding region sequence, 1-753 include transmembrane domains (having underscore part), and 754-2328 polymerize comprising RNA Enzymatic activity is removed 1-753 in sequence transmembrane domains by truncating or being mutated, and 754-2328 using in sequence as RNA mould Plate synthesizes complementary strand RNA, and RNA yield is 95% or more of template ribonucleic acid amount.
Beneficial effects of the present invention:
The present invention is sick using the xiangshizhubanbo of transmembrane region or cross-film region mutation containing polymerase domain and without the end N- Poison belongs to virus for basic preparation and reorganization albumen, and RNA yield is greater than 1mg/mL, is suitble to the synthesis and production of industrialization RNA.
Detailed description of the invention
Present invention is further described in detail in the following with reference to the drawings and specific embodiments.
Fig. 1 is the replication protein coding region sequence of turnip crinkle virus.
Specific embodiment
The technical scheme in the embodiments of the invention will be clearly and completely described below, it is clear that described implementation Example is only a part of the embodiment of the present invention, instead of all the embodiments.Based on the embodiments of the present invention, this field is common Technical staff's all other embodiment obtained without creative efforts belongs to the model that the present invention protects It encloses.
Embodiment 1
A kind of RNA polymerase preparation method that RNA is relied on, includes the following steps:
A, turnip crinkle virus is chosen as raw material;
B, using the transmembrane region for the end N- for truncating or being mutated removing viral RNA, to remove the cytotoxicity of virus protein And enhance the solubility of recombinant protein;
C, the synthesis of RNA polymerase is carried out in the cell or extracellularly by prokaryotic expression or eukaryotic expression.
The specific method for removing the transmembrane region of the end N- in the step b by mutation is deletion mutation;
Specifically, when preparing target RNA in the cell, by the building of polymerase template ribonucleic acid in carrier for expression of eukaryon, true In nucleus after expression, complementary strand RNA is synthesized using intracellular target template RNA;The carrier for expression of eukaryon is dynamic for lactation Object expression vector;
Polymerase template ribonucleic acid is wherein constructed into the method in carrier for expression of eukaryon are as follows:
The adhere-wall culture of S1, cell
Cell to be transfected is added in culture bottle, cell to be transfected, after cleaning, Xiang Qi are cleaned by PBS buffer solution Middle addition pancreatin is digested by pancreatin and decomposes extracellular protein, so that the cell being bonded together be made to separate, passes through micro- sem observation Cell separates situation, when cell is without large stretch of connection, serum is added into culture bottle, wherein serum is able to suppress and destroys pancreas Enzymatic activity makes its failure, prevents pancreatin excessive decomposition extracellular protein, damages to cell itself;
Centrifugation obtains agglomerate cell, is centrifuged again after being cleaned by PBS buffer solution, PBS buffer solution is removed, into cell MEM culture medium is added and dispels cell, cell culture medium is added in culture bottle, in the environment of 37 DEG C, 5% carbon dioxide Stationary culture, keeps cell adherent and flanking cell does not bond mutually, and wherein the adherent area of cell accounts for culture bottle bottom of bottle area 63%;
The case where cell of culture is separated first in the step, avoids the occurrence of multiple cell agglomerates, to cell phase Mutually after dispersion, then the cell being dispersed is cultivated, makes cell adherent growth, be able to ascend in this way cell expose it is thin The area of after birth;
The preparation of S2, transfection liquid
Polylea non-liposomal transfection reagent is added into physiological saline, ethyl alcohol is added thereto after concussion is uniformly dispersed With A23187 carrier, it is stand-by that precursor is obtained after concussion dispersion;
The polymerase template ribonucleic acid for being 0.1-1g/L by MEM culture medium compound concentration, is then added dropwise in precursor, Container is constantly shaken during being added dropwise, and is uniformly mixed the two;
S3, transfection
After the culture bottle that inner wall adherent growth obtained in step S1 has cell is taken out, culture solution is poured out, to culture Transfection liquid is added dropwise in bottle, and transfection liquid slides into along bottle wall when dropwise addition, prevents cell and culture bottle of the droplet impact power by adherent growth Separation;
By culture bottle in the environment of 37 DEG C, 5% carbon dioxide after stationary culture 15min, it is ultrasonically treated 20min, then Transfection is completed after cultivating 6h in the environment of 37 DEG C, 5% carbon dioxide.
During being ultrasonically treated, in order to guarantee that the uniformity of ultrasound, ultrasound occur point and culture bottle are arranged in Underface;
By the way that duplex structure will be formed with the short rna of target template RNA complementary pairing and template, made using the duplex structure For primer, the synthesis of complementary strand RNA can be promoted, improve RNA combined coefficient;
As shown in Figure 1, in the replication protein coding region sequence of the turnip crinkle virus, 1-753 comprising transmembrane domains (i.e. Have underscore part), 754-2328 include rna polymerase activity, wear film for 1-753 in sequence by truncating or being mutated Area removes, and 754-2328 using in sequence synthesize complementary strand RNA as RNA template, and RNA yield is template ribonucleic acid amount 95% or more.
Embodiment 2
A kind of RNA polymerase preparation method that RNA is relied on, includes the following steps:
A, turnip crinkle virus is chosen as raw material;
B, using the transmembrane region for the end N- for truncating or being mutated removing viral RNA, to remove the cytotoxicity of virus protein And enhance the solubility of recombinant protein;
C, the synthesis of RNA polymerase is carried out in the cell or extracellularly by prokaryotic expression or eukaryotic expression.
By truncating the specific method for the transmembrane region for removing the end N- as deletion mutation in the step b;
When preparing target RNA in the cell, by the building of polymerase template ribonucleic acid in carrier for expression of eukaryon, in eukaryocyte After interior expression, complementary strand RNA is synthesized using intracellular target template RNA;The carrier for expression of eukaryon is Yeast expression carrier;
Polymerase template ribonucleic acid is wherein constructed into the method in carrier for expression of eukaryon are as follows:
The adhere-wall culture of S1, cell
Cell to be transfected is added in culture bottle, cell to be transfected, after cleaning, Xiang Qi are cleaned by PBS buffer solution Middle addition pancreatin is digested by pancreatin and decomposes extracellular protein, so that the cell being bonded together be made to separate, passes through micro- sem observation Cell separates situation, when cell is without large stretch of connection, serum is added into culture bottle, wherein serum is able to suppress and destroys pancreas Enzymatic activity makes its failure, prevents pancreatin excessive decomposition extracellular protein, damages to cell itself;
Centrifugation obtains agglomerate cell, is centrifuged again after being cleaned by PBS buffer solution, PBS buffer solution is removed, into cell MEM culture medium is added and dispels cell, cell culture medium is added in culture bottle, in the environment of 37 DEG C, 5% carbon dioxide Stationary culture, keeps cell adherent and flanking cell does not bond mutually, and wherein the adherent area of cell accounts for culture bottle bottom of bottle area 71%;
The case where cell of culture is separated first in the step, avoids the occurrence of multiple cell agglomerates, to cell phase Mutually after dispersion, then the cell being dispersed is cultivated, makes cell adherent growth, be able to ascend in this way cell expose it is thin The area of after birth;
The preparation of S2, transfection liquid
Polylea non-liposomal transfection reagent is added into physiological saline, ethyl alcohol is added thereto after concussion is uniformly dispersed With A23187 carrier, it is stand-by that precursor is obtained after concussion dispersion;
The polymerase template ribonucleic acid for being 1g/L by MEM culture medium compound concentration, is then added dropwise in precursor, is added dropwise Container is constantly shaken in the process, is uniformly mixed the two;
S3, transfection
After the culture bottle that inner wall adherent growth obtained in step S1 has cell is taken out, culture solution is poured out, to culture Transfection liquid is added dropwise in bottle, and transfection liquid slides into along bottle wall when dropwise addition, prevents cell and culture bottle of the droplet impact power by adherent growth Separation;
By culture bottle in the environment of 37 DEG C, 5% carbon dioxide after stationary culture 15min, it is ultrasonically treated 25min, then Transfection is completed after cultivating 6.5h in the environment of 37 DEG C, 5% carbon dioxide.
During being ultrasonically treated, in order to guarantee that the uniformity of ultrasound, ultrasound occur point and culture bottle are arranged in Underface;
By the way that duplex structure will be formed with the short rna of target template RNA complementary pairing and template, made using the duplex structure For primer, the synthesis of complementary strand RNA can be promoted, improve RNA combined coefficient;
In the replication protein coding region sequence of the turnip crinkle virus, 1-753 (have underscore portion comprising transmembrane domains Point), 754-2328 include rna polymerase activity, 1-753 in sequence transmembrane domains are removed by truncating or being mutated, with 754-2328 synthesize complementary strand RNA as RNA template in sequence, and RNA yield is 95% or more of template ribonucleic acid amount.
Above content is only to structure of the invention example and explanation, affiliated those skilled in the art couple Described specific embodiment does various modifications or additions or is substituted in a similar manner, without departing from invention Structure or beyond the scope defined by this claim, is within the scope of protection of the invention.

Claims (10)

1. the RNA polymerase preparation method that a kind of RNA is relied on, which comprises the steps of:
A, the Carmovirus virus of Tombusviridae is chosen as raw material;
B, using the transmembrane region for the end N- for truncating or being mutated removing viral RNA, template ribonucleic acid is obtained;
C, the synthesis of RNA polymerase is carried out in the cell or extracellularly by prokaryotic expression or eukaryotic expression.
2. the RNA polymerase preparation method that a kind of RNA according to claim 1 is relied on, which is characterized in that the step b In by mutation remove the end N- transmembrane region specific method be deletion mutation or point mutation.
3. the RNA polymerase preparation method that a kind of RNA according to claim 1 is relied on, which is characterized in that the tomato clump The Carmovirus virus of dwarf virus section is specially turnip crinkle virus.
4. the RNA polymerase that the RNA polymerase preparation method that a kind of RNA according to claim 1 is relied on is prepared, It is characterized in that, the RNA polymerase for preparing target RNA in the cell or extracellularly.
5. the application of RNA polymerase according to claim 4, which is characterized in that first in extracellularly preparation target RNA First RNA polymerase purifies after passing through prokaryotic expression or eukaryotic expression, becomes enzyme preparation, in extracellular buffered environment, benefit Complementary strand RNA is synthesized with target template RNA.
6. the application of RNA polymerase according to claim 4, which is characterized in that, will when preparing target RNA in the cell Polymerase template ribonucleic acid constructs in carrier for expression of eukaryon, after expressing in eukaryocyte, utilizes intracellular target template RNA Synthesize complementary strand RNA.
7. the application of RNA polymerase according to claim 6, which is characterized in that constructing polymerase template ribonucleic acid in eukaryon Method in expression vector are as follows:
The adhere-wall culture of S1, cell
By cell to be transfected be added culture bottle in, cell to be transfected is cleaned by PBS buffer solution, after cleaning, thereto plus Enter pancreatin, digested by pancreatin and decompose extracellular protein, so that the cell being bonded together be made to separate, then blood is added into culture bottle Clearly, pancreatin is made to fail;
Centrifugation obtains agglomerate cell, is centrifuged again after being cleaned by PBS buffer solution, PBS buffer solution is removed, be added into cell MEM culture medium simultaneously dispels cell, and cell culture medium is added in culture bottle, is stood in the environment of 37 DEG C, 5% carbon dioxide Culture, keeps cell adherent and flanking cell does not bond mutually, wherein the adherent area of cell accounts for the 60%- of culture bottle bottom of bottle area 80%;
The preparation of S2, transfection liquid
Into physiological saline be added polylea non-liposomal transfection reagent, concussion be uniformly dispersed after, thereto be added ethyl alcohol with It is stand-by to obtain precursor after concussion dispersion for A23187 carrier;
The polymerase template ribonucleic acid for being 0.1-1g/L by MEM culture medium compound concentration, is then added dropwise in precursor, is added dropwise Container is constantly shaken in the process, is uniformly mixed the two;
S3, transfection
After the culture bottle that inner wall adherent growth obtained in step S1 has cell is taken out, culture solution is poured out, into culture bottle Transfection liquid is added dropwise, transfection liquid slides into along bottle wall when dropwise addition;
By culture bottle in the environment of 37 DEG C, 5% carbon dioxide after stationary culture 10-15min, it is ultrasonically treated 20-26min, so Transfection is completed after cultivating 4-8h in the environment of 37 DEG C, 5% carbon dioxide afterwards;
During being ultrasonically treated, the underface that culture bottle is arranged in point occurs for ultrasound, and point and culture occur for ultrasound The distance between bottle >=15cm.
8. the application of RNA polymerase according to claim 6, which is characterized in that the carrier for expression of eukaryon includes lactation Animal expression vector, insect expression vector, Yeast expression carrier.
9. the application of RNA polymerase according to claim 4, which is characterized in that by with target template RNA complementary pairing Short rna and the template ribonucleic acid form duplex structure, and using the duplex structure as primer, synthesize complementary strand RNA.
10. the application of RNA polymerase according to claim 4, which is characterized in that set the 3 ' ends of target template RNA It is calculated as matching with self-complementary, and using the end RNA after pairing as primer, synthesizes complementary strand RNA.
CN201910457310.9A 2019-05-29 2019-05-29 A kind of RNA polymerase preparation method and application that RNA is relied on Pending CN110079511A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910457310.9A CN110079511A (en) 2019-05-29 2019-05-29 A kind of RNA polymerase preparation method and application that RNA is relied on

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910457310.9A CN110079511A (en) 2019-05-29 2019-05-29 A kind of RNA polymerase preparation method and application that RNA is relied on

Publications (1)

Publication Number Publication Date
CN110079511A true CN110079511A (en) 2019-08-02

Family

ID=67422377

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910457310.9A Pending CN110079511A (en) 2019-05-29 2019-05-29 A kind of RNA polymerase preparation method and application that RNA is relied on

Country Status (1)

Country Link
CN (1) CN110079511A (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040265821A1 (en) * 2001-07-30 2004-12-30 Volker Sandig Rna amplication system using plant components in animal cells
CN101168781A (en) * 2007-10-17 2008-04-30 李越希 In vitro activity measuring method for hepatitis C virus RNA depending RNA polymerase and application thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040265821A1 (en) * 2001-07-30 2004-12-30 Volker Sandig Rna amplication system using plant components in animal cells
CN101168781A (en) * 2007-10-17 2008-04-30 李越希 In vitro activity measuring method for hepatitis C virus RNA depending RNA polymerase and application thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
K. S. RAJENDRAN等: "Comparison of Turnip Crinkle Virus RNA-Dependent RNA Polymerase Preparations Expressed in Escherichia coli or Derived from Infected Plants", 《JOURNAL OF VIROLOGY》 *

Similar Documents

Publication Publication Date Title
US11807870B2 (en) Cellular microcompartment and preparation processes
Contreras‐Gómez et al. Protein production using the baculovirus‐insect cell expression system
Want et al. Large-scale expansion and exploitation of pluripotent stem cells for regenerative medicine purposes: beyond the T flask
JP6177260B2 (en) Method for producing a polypeptide or virus of interest in continuous cell culture
KR101348325B1 (en) Method for purifying cardiac myocyte and presumptive cardiac myocyte derived from stem cell and fetus
EP2366719B1 (en) Process of production of a recombinant polypeptide by fusion with an autoprotease
Rezanejad et al. In vitro differentiation of adipose-tissue-derived mesenchymal stem cells into neural retinal cells through expression of human PAX6 (5a) gene
IL268868A (en) Novel method of protein purification
WO2002042326A8 (en) A method of expression and agents identified thereby
US20240200042A1 (en) Limited self-replicating mrna molecular system, producing method and use
Xu et al. A protocell with fusion and division
CN110079511A (en) A kind of RNA polymerase preparation method and application that RNA is relied on
CN109983118B (en) Induction of hepatocytes by stem cell differentiation with RNA
CN107287158A (en) The method of effective acquisition mescenchymal stem cell from mouse dense bone
US20170009269A1 (en) Enhancement of recombinant protein expression using a membrane-based cell retention system
Royster et al. A novel approach for the purification of aggregation prone proteins
NZ724826A (en) A high cell density fill and draw fermentation process
US20230059873A1 (en) Expansion of stem cells in suspension in a bioreactor
Gotlib et al. Plasma membrane isolation on DEAE-Sephadex beads
CN104630137B (en) The method of one boar ICSI operations
CN104498478A (en) Genome extraction method for improving DNA quality of myxobacteria by virtue of pretreatment
NZ794605A (en) Neural tissue unit and use of such a unit for implantation in the nervous system of a mammal
NZ794660A (en) Cellular microcompartment and preparation methods
Shenoy Animal biotechnology
CN106434528B (en) A kind of regeneration method and its application of microcarrier

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination